{"version":"1.0","provider_name":"Neuraxpharm Belgique","provider_url":"https:\/\/www.neuraxpharm.com\/be-fr","author_name":"Jaime Fern\u00e1ndez","author_url":"https:\/\/www.neuraxpharm.com\/be-fr\/blog\/auteur\/jaime","title":"MIGUEL BARRERO","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"R6l7bKHCoB\"><a href=\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\">MIGUEL BARRERO<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\/embed#?secret=R6l7bKHCoB\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0MIGUEL BARRERO\u00a0\u00bb &#8212; Neuraxpharm Belgique\" data-secret=\"R6l7bKHCoB\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.neuraxpharm.com\/be-fr\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm MIGUEL BARRERO Miguel Barrero Dur\u00e1n est Head of Business Development &amp; Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle. Il a [&hellip;]","thumbnail_url":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/m-barrero.jpg"}